Schonfeld Strategic Advisors LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$11.07 - $16.04 $141,696 - $205,312	12,800 New	12,800 $151,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $418,586 - $723,086	-40,600 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.6 - $21.67 $763,280 - $1.43 Million	-65,800 Reduced 61.84%	40,600 $471,000
Q2 2019 Aug 14, 2019	BUY	$18.44 - $30.89 $1.76 Million - $2.95 Million	95,400 Added 867.27%	106,400 $2.36 Million
Q1 2019 May 15, 2019	BUY	$16.51 - $31.1 $181,610 - $342,100	11,000 New	11,000 $315,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $248M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.